Tempest Therapeutics Stock Pattern Recognition Tristar Pattern

TPST Stock

USD 2.26 -0.03 -1.31%

The pattern recognition module provides an execution environment for Tristar Pattern recognition and related indicators on Tempest Therapeutics. The analysis highlights pattern recognition signals tied to momentum and continuation and frames technical signals with volatility and risk context.

Symbol

Recognition

The function did not generate any output. Please change time horizon or modify your input parameters. This analysis covers forty-nine data points across the selected time horizon. The function did not return any valid pattern recognition events for the selected time horizon. The Tristar Pattern is relatively rare and usually implies Tempest Therapeutics reversal in the current trend.

Tempest Therapeutics Technical Analysis Modules

Most technical analysis of Tempest Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Tempest from various momentum indicators to cycle indicators. When you analyze Tempest charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

Stock Overview, Methodology & Data Sources

Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. Tempest Therapeutics Inc. was formerly a subsidiary of Inception Sciences, Inc. Tempest Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 17 people. Liquidity and trading activity can influence how quickly new information is reflected in Tempest Therapeutics's price. Lower trading activity may introduce occasional variability in execution conditions. Tempest Therapeutics has a market cap of 30.47 M, P/E of 0.23, ROE of -4.05%.

Methodology

Unless otherwise specified, financial data for Tempest Therapeutics is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Tempest (USA Stocks:TPST) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: The dataset for Tempest Therapeutics incorporates public filings and market reference sources and official institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Some inputs may not update instantaneously. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Tempest Therapeutics has active sell-side coverage. Source-validated coverage currently shows 1 approved analyst, while broader market-consensus totals may differ across providers due to methodology and update timing. Representative analyst firms may include RBC Capital Markets, Barclays, HSBC Global Research, Wells Fargo Securities, Bank of America Securities, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Rifka Kats - Member of Macroaxis Editorial Board

Last reviewed on February 28th, 2026

Align your values with your investing style

Tempest Therapeutics operates in Healthcare/Biotechnology at 30.47 Million market cap - a thematic view expands this smaller-cap position into a broader portfolio concept. For Tempest Therapeutics in Biotechnology, the theme workflow defines the investment thesis first, then optimizes which Healthcare assets best express that view at the smaller-cap level.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.

	Momentum Invested few shares	Go
	Macroaxis Index Invested over 60 shares	Go
	Corona Opportunity Invested few shares	Go
	Investor Favorites Invested over 20 shares	Go
	Advertising Invested few shares	Go
	Hedge Favorites Invested few shares	Go
	Driverless Cars Invested over 40 shares	Go
	Video Games Invested few shares	Go
	Baby Boomer Prospects Invested over 20 shares	Go
	Social Domain Invested few shares	Go
	Artificial Intelligence Invested few shares	Go

Additional Tools for Tempest Stock Analysis

	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC